Become A Featured Company

CBD 101 – Where to Buy & How Much to Take

Lukas Barfield

March 2nd, 2017

Policy

Cannabidiol or CBD is one of the primary chemical constituents of the cannabis sativa plant. This often misunderstood plant is also known as marijuana or hemp. Although CBD’s therapeutic effects have been known for many years, its much maligned cousin, Tetrahydrocannabinol (THC), has over shadowed Cannabidiol. That is until recently, when avalanches of CBD products and new state regulations have swept the country, and in 2014 Dr Sanjay Gupta’s well publicized documentary “Weed”, helped reignite the conversation around CBd. Despite the reinvigorated conversation, many questions remain for consumers in the sometimes confusing CBD landscape like  “What is CBD Oil?”, “Is it legal?””, “Where can I get CBD Oil?”, “What are some considerations When buying CBd Oil?” and “What are some things to watch for when consuming Cannabidiol?”

Intro to CBD

Cannabidiol is one of 80 different cananbinoids found in the cannabis plant. Like THC it interacts with the endocannabinoid system in the body and has many therapeutic properties, but unlike THC, CBD is not psychoactive. Since it was first isolated in the lab in 1963, CBD has been found to have Anti-tumoral, anti-oxidant, anti-spasmodic, anti-psychotic, anti-convulsive, anti-inflammatory and neuroprotective properties. These make CBD a viable treatment for many conditions such as parkensens disease, Alzheimer’s, rumatoid arthritis, diabetes, MS, Epilepsy, Schizophrenia, inflammatory conditions and cancer. There are two types of CBD oil, hemp CBD oil, which is made from hemp, and in most products sold online and legal in all 50 states, and full plant CBD oil, which is made from cannabis and is available in medical cannabis states around the country.

Buying CBD Considerations

Source Material Hemp, a cannabis plant bread for its fiber and has a THC concentration less than 0.3%, is the most common source for CBD oil, but some CBD products are made from cannabis plants with a THC concentration greater than 0.3%. These are known as full plant CBD oils. Thus, depending on what state you live in, some CBD products may have a THC concentration greater than 0.3%. Before buying CBD products, be sure to check the THC concentrations to avoid unwanted effects, and know what products are allowed in your state.

In addition, buyers should look for CBD extracted from certified organic source material in order to avoid pesticides and other contaminants. CBD oil extracted from Imported Chinese hemp MAY be contaminated.

Extraction Method Supercritical CO2 extraction is the safest extraction method for consumers and labs, and produces the purest CBD oil. These products can be expensive. If price is an issue for the CO2 CBD oil, extractions using food grade ethanol are a safe alternative. Less expensive brands may use hydrocarbon extraction (butane etc.), but may not always be the safest for consumption. Low cost can be a red flag for inferior products.

Measurements The concentration of CBD should be clearly noted on each product. If buying capsules, pay close attention to if the measurements are per capsule, or per bottle. Reputable venders, like Medical Marijuana Inc. who’s Real Science Hemp Oil (RSHO) is a trusted CBD source, should have lab results available to check CANNABINOID concentration claims. If you have any questions, don’t hesitate to ask the vender before buying.

CBD Consumption Basics

CBD and other cananbinoids are soluble in alcohol and oils/fats. As a result, there are hundreds of available products. Balms, sabs, capsules, gummies, cookies, sprays, tinctures, vape cartridges and lip balms are just a few products out there. Each one can have an entire array of dosing options, and consumers should pay close attention to the amount of CBD in each dose.

Experts agree that when starting a new cannabis therapy, start low and adjust your dose according to the effectiveness of the treatment. The Mayo Clinic gives some CBD and THC dosing guidance according to disease, but each individual will have unique medicating needs. Finally, it is always a good idea to consult with a doctor before starting any new health care regiment.

To learn more about cannabis oil and related topics, sign-up for our free newsletter using the form to the right.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Lukas Barfield

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading